» Articles » PMID: 2141871

Atrophy of the Hypothalamic Lateral Tuberal Nucleus in Huntington's Disease

Overview
Specialties Neurology
Pathology
Date 1990 Jul 1
PMID 2141871
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

The hypothalamic lateral tuberal nucleus (NTL) was studied in the formalin-fixed brains of five patients with Huntington's disease (HD) and in five age- and sex-matched controls. With the Klüver-Barrera (luxol fast blue/cresyl violet) and hematoxylin and eosin stains the NTL was defined by its cytoarchitectonic characteristics. The nucleus was composed of one type of neuron and had about 60,000 cells. In HD, up to 90% neuronal loss was found in the NTL. The remaining neurons showed features of degeneration and there was astrocytosis. The estimated total number of glial cells in the NTL was reduced to 80% of the control values, which was exclusively accounted for by a reduction of 40% in the number of oligodendrocytes. The total number of astrocytes was unchanged. Grouping of astrocytes and the changes observed in glial fibrillary acidic protein immunocytochemistry suggested that astrocytic proliferation occurred.

Citing Articles

Neuroleptic malignant syndrome in Huntington disease.

Funcis A, Ravera B, Zinzi P, Solito M, Petracca M, Calabresi P Eur J Neurol. 2024; 31(12):e16442.

PMID: 39444167 PMC: 11554869. DOI: 10.1111/ene.16442.


Cell Rearrangement and Oxidant/Antioxidant Imbalance in Huntington's Disease.

DEgidio F, Castelli V, Cimini A, dAngelo M Antioxidants (Basel). 2023; 12(3).

PMID: 36978821 PMC: 10045781. DOI: 10.3390/antiox12030571.


Exploration of the Shared Molecular Mechanisms between COVID-19 and Neurodegenerative Diseases through Bioinformatic Analysis.

Shi Y, Liu W, Yang Y, Ci Y, Shi L Int J Mol Sci. 2023; 24(5).

PMID: 36902271 PMC: 10002862. DOI: 10.3390/ijms24054839.


The role of neuropeptide somatostatin in the brain and its application in treating neurological disorders.

Song Y, Yoon J, Lee S Exp Mol Med. 2021; 53(3):328-338.

PMID: 33742131 PMC: 8080805. DOI: 10.1038/s12276-021-00580-4.


Is the Immunological Response a Bottleneck for Cell Therapy in Neurodegenerative Diseases?.

Salado-Manzano C, Perpina U, Straccia M, Molina-Ruiz F, Cozzi E, Rosser A Front Cell Neurosci. 2020; 14:250.

PMID: 32848630 PMC: 7433375. DOI: 10.3389/fncel.2020.00250.